Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Business Model:
Revenue: $0
Employees: 201-500
Rankings
Industries / Tags:
Detailed Alphamab Oncology Information
Geographic Data
Address: 175 Fangzhou Road
City: Suzhou
State: shanghai municipality
Zip: 215125
Country: CN
Financial Info
Stage:
Raised Last:
$60M
Raised Total:$160M
Social
Linkedin
Crunchbase
Metrics
6,138,680Website Global Rank
1,187Website Monthly Traffic
Twitter Followers
Description
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipeline in oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally.
Contact Phone:
Contact Email:
Alphamab Oncology went public on 12/12/2019 on the HKG
Listed Exchange:
HKG
IPO Date:
12/12/2019
IPO Valuation:
$235M
Ticker Symbol:
9966
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2016 | SmartNuclide | Angel Round | 0 |
| 3/2016 | SmartNuclide | Angel Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
